Economic analysis of oral and topical therapies for onychomycosis of the toenails and fingernails.

Managed care (Langhorne, Pa.)

Volumn 12, Issue 3, 2003, Pages 47-54

  Casciano, Julian ^a   Amaya, Karine ^a   Doyle, John ^a   Arikian, Steve ^a   Shear, Neil ^a   Haspel, Marc ^a   Kahler, Kristijan ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; CICLOPIROX; ITRACONAZOLE; NAPHTHALENE DERIVATIVE; PYRIDONE DERIVATIVE; TERBINAFINE;

ADULT; ARTICLE; CLASSIFICATION; CLINICAL TRIAL; COST BENEFIT ANALYSIS; DRUG COST; ECONOMICS; HAND DISEASE; HEALTH INSURANCE; HUMAN; META ANALYSIS; ONYCHOMYCOSIS; PHARMACOECONOMICS; SKIN DISEASE; STATISTICS; UNITED STATES;

ADULT; ANTIFUNGAL AGENTS; COST-BENEFIT ANALYSIS; DRUG COSTS; ECONOMICS, PHARMACEUTICAL; FOOT DERMATOSES; HAND DERMATOSES; HUMANS; ITRACONAZOLE; MANAGED CARE PROGRAMS; NAPHTHALENES; ONYCHOMYCOSIS; PYRIDONES; UNITED STATES;

EID: 0038411458     PISSN: 10623388     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)